Clinical trials
Phase 1/2 trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 3 |
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 9 |
| Enrolling by invitation | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ziauddin University | 5 |
| Dow University of Health Sciences | 4 |
| University of Health Sciences Lahore | 4 |
| Benazir Bhutto Hospital, Rawalpindi | 3 |
| Liaquat National Hospital & Medical College | 3 |
| National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 3 |
| Sohaib Ashraf | 3 |
| ARI Research Cell | 2 |
| Aga Khan University | 2 |
| Shifa International Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 4 |
| Hypertension | 3 |
| Pneumonia | 3 |
| Coronavirus Infections | 2 |
| Oral Submucous Fibrosis | 2 |
| Schizophrenia | 2 |
| Tooth, Nonvital | 2 |
| Acute Coronary Syndrome | 1 |
| Alopecia | 1 |
| Anemia | 1 |
Trials
Showing 51 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.